Skip to main content
. 2015 Mar 25;86(2):264–269. doi: 10.3109/17453674.2014.964621

Figure 2.

Figure 2.

Daily exposure to HBO suppresses RANKL-induced bone resorption in a treatment number-dependent manner. Human PBMCs were incubated on bone slices in the presence of RANKL (30 ng/mL) and M-CSF (50 ng/mL) for 21 days. Following incubation, the percentage of bone surface displaying resorption pits was analyzed by reflected light microscopy. Control cultures (panel A), pre-HBO (B), 10 HBO treatments (C), and 25 HBO treatments (D). Values are mean ± SEM (n = 6).